NCT07248124

Brief Summary

The Scratch Collapse Test (SCT) is a neurocutaneous reflex used to detect peripheral nerve compression in nerve tunnel syndromes. It first involves applying a sensory stimulus to the skin over the suspected nerve compression point, then bilaterally testing the strength of a specific muscle in the patient. Compression is then manifested by a transient loss of strength in the muscle on the affected side, while it is preserved on the healthy side. This loss of strength is transient and disappears after a few seconds. This test can be performed during a patient's clinical examination, with the physician assessing strength or, conversely, muscle collapse. However, while several articles have described the relevance of this test, as well as its sensitivity and specificity, no study has specifically investigated and measured this observed loss of eccentric muscle tone and its unilateral and transient nature, even though the phenomenon of CSP (cutaneous silent period) has been described. We therefore propose to analyze the myographic tracing obtained in patients diagnosed with unilateral carpal tunnel syndrome. A transient loss of muscle tone is expected by selective needle myography on the pathological side after cutaneous sensory stimulation of the wrist, while cutaneous sensory stimulation on the healthy side does not alter the tracings obtained by myography.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 4, 2025

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

November 17, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 25, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 4, 2026

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 5, 2026

Completed
Last Updated

November 25, 2025

Status Verified

November 1, 2025

Enrollment Period

6 months

First QC Date

November 17, 2025

Last Update Submit

November 21, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Evolution of the myographic tracings

    Evolution of the myographic tracings (of the infraspinatus muscle) of the pathological arm immediately after ipsilateral stimuli compared to the basic tracings (before stimuli) of the pathological arm and evolution of the myographic tracings of the pathological arm 20 seconds after ipsilateral stimuli compared to the basic tracings (before stimuli) of the pathological arm.

    one day

Study Arms (1)

Patient with unilateral carpal tunnel syndrome

EXPERIMENTAL

Patient with clinical unilateral carpal tunnel syndrome diagnosed by history, clinical examination and electromyography,

Procedure: electromyographDiagnostic Test: Scratch Collapse Test

Interventions

This examination uses electrodes placed along the path of the median nerve to measure the transmission of nerve impulses (conduction studies). It is performed on both hands to compare the results.

Patient with unilateral carpal tunnel syndrome
Scratch Collapse TestDIAGNOSTIC_TEST

The Scratch Collapse Test (SCT) is a neurocutaneous reflex used to detect peripheral nerve compression in nerve canal syndromes. It involves first performing a sensory stimulus on the skin at the suspected nerve compression site, then bilaterally testing the strength of a specific muscle in the patient. Compression is then manifested by a transient loss of strength in the muscle on the affected side, while it is preserved on the stimulated side.

Patient with unilateral carpal tunnel syndrome

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient over 18 years old
  • Patient with clinical unilateral carpal tunnel syndrome diagnosed by history, clinical examination and electromyography,
  • Patient who has been informed and has given their free, informed, and written consent,
  • Patient affiliated with or beneficiary of a social security scheme.

You may not qualify if:

  • Other associated canal syndrome on either side (ulnar, defilement, lacertus),
  • Rotator cuff pathology, insufficiency or rupture of the infraspinatus,
  • Associated cervical pathology,
  • Neuropathy, central or peripheral neurological disease,
  • Diabetic patient,
  • Patient with cognitive impairments that prevent the understanding of the study information,
  • Refusal to participate in the study,
  • Pregnant, parturient, or breastfeeding woman,
  • Patient under legal protection,
  • Patient not receiving health protection,
  • Protected patient: adult under guardianship, curatorship, or other legal protection, deprived of liberty by judicial or administrative decision

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinique de l'Ormeau

Tarbes, 65000, France

RECRUITING

MeSH Terms

Conditions

Carpal Tunnel Syndrome

Condition Hierarchy (Ancestors)

Median NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNerve Compression SyndromesCumulative Trauma DisordersSprains and StrainsWounds and Injuries

Central Study Contacts

Vincent Martinel, Dr

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 17, 2025

First Posted

November 25, 2025

Study Start

November 4, 2025

Primary Completion

May 4, 2026

Study Completion

May 5, 2026

Last Updated

November 25, 2025

Record last verified: 2025-11

Locations